Eli Lilly 'On Its Way' To $1 Trillion Market Cap, Analysts Say: It's A 'Have' In A Sea Of 'Have Nots'
Portfolio Pulse from Vandana Singh
Eli Lilly (LLY) is on track to reach a $1 trillion market cap, according to Cantor Fitzgerald analysts, following a strong earnings report with Q1 revenue of $8.77 billion, up 26% year-over-year. Despite a slight miss on revenue expectations, adjusted EPS was $2.58, beating the consensus. Price targets have been raised by Cantor, BofA, and Truist, citing impressive growth and the potential of its incretin franchise and Mounjaro/Zepbound.
May 01, 2024 | 7:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly's strong Q1 earnings and positive analyst ratings, with raised price targets, indicate a bullish outlook for the stock.
Eli Lilly's Q1 earnings report showed significant revenue growth and an EPS beat, leading to positive analyst ratings and increased price targets from Cantor Fitzgerald, BofA, and Truist. This reflects confidence in the company's growth trajectory and its potential to reach a $1 trillion market cap, suggesting a likely positive short-term impact on LLY's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100